Clinical trial
The Cardio-protective Effect of Cardiomyopeptidin on Myocardial Injury in ICU Patients With Non-organic Heart Disease: a Prospective, Randomized Controlled Pilot Study
NCT06117046 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Cardio-protective Effect of Cardiomyopeptidin on Myocardial Injury in ICU Patients With Non-organic Heart Disease: a Prospective, Randomized Controlled Pilot Study
- Lead sponsor
- Nanfang Hospital, Southern Medical University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 1, 2024
- Completion date
- December 30, 2024
- Enrollment
- 234 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
icu, myocardial injury